Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

CYCLERION THERAPEUTICS, INC. (KRSA) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

CYCLERION THERAPEUTICS, INC. (KRSA), most recent 12 months reported: revenue $2.07M, net loss $3.53M. Latest balance sheet on file: liquid cash $3.24M. From SEC filings. Others in Pharmaceutical Preparations: PMGC HOLDINGS INC. · VISTAGEN THERAPEUTICS, INC. · Korro Bio, Inc. · NORTHWEST BIOTHERAPEUTICS INC · Dianthus Therapeutics, Inc. /DE/ · ORAMED PHARMACEUTICALS INC. · Seres Therapeutics, Inc. · CANNAPHARMARX, INC.

Stock screener

Watchlist